Geert D'Haens Selected Research

Geert D'Haens Research Topics

Disease

86	Crohn Disease (Crohn's Disease) 10/2022 - 09/2002
47	Ulcerative Colitis 02/2022 - 10/2002
22	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 12/2021 - 03/2006
13	Infections 10/2022 - 06/2007
12	Inflammation (Inflammations) 12/2017 - 01/2003
11	Ulcer 01/2022 - 10/2004
10	Necrosis 01/2022 - 06/2011
6	Neoplasms (Cancer) 01/2018 - 04/2009
5	Hemorrhage 01/2022 - 05/2016
4	Fistula 07/2018 - 12/2002
4	Colitis 01/2016 - 09/2002
2	Herpes Zoster 10/2022 - 01/2020
2	Injection Site Reaction 01/2022 - 01/2020
2	Abdominal Pain (Pain, Abdominal) 01/2022 - 01/2022
2	Pulmonary Embolism 01/2022 - 01/2020
2	Multiple Sclerosis 01/2018 - 08/2015
2	Pathologic Complete Response 01/2018 - 09/2006
2	Anemia 05/2016 - 05/2008
2	Sepsis (Septicemia) 09/2014 - 06/2013
2	Body Weight (Weight, Body) 03/2014 - 04/2010
2	Proctitis 12/2008 - 10/2002
2	Proctocolitis (Hemorrhagic Proctocolitis) 12/2008 - 10/2002
1	Respiratory Tract Infections (Respiratory Tract Infection) 01/2022
1	Arthralgia (Joint Pain) 01/2022
1	Psoriasis (Pustulosis Palmaris et Plantaris) 01/2022
1	Disease Progression 01/2022
1	Nasopharyngitis 01/2022
1	Acne Vulgaris 01/2022
1	Encephalitis (Encephalitis, Rasmussen) 10/2020
1	Hepatocellular Carcinoma (Hepatoma) 10/2020
1	West Nile Fever 10/2020
1	Venous Thrombosis (Deep-Vein Thrombosis) 01/2020
1	Chronic Disease (Chronic Diseases) 02/2019
1	Progressive Multifocal Leukoencephalopathy 01/2018
1	Leukopenia 01/2018
1	Lymphoproliferative Disorders (Lymphoproliferative Disorder) 06/2017

Drug/Important Bio-Agent (IBA)

30	Infliximab (Remicade)FDA Link 01/2022 - 09/2002
14	Adrenal Cortex Hormones (Corticosteroids)IBA 02/2022 - 02/2008
13	Adalimumab (Humira)FDA Link 01/2022 - 06/2007
12	Pharmaceutical PreparationsIBA 01/2022 - 01/2012
10	vedolizumabIBA 01/2022 - 09/2014
9	Monoclonal AntibodiesIBA 01/2022 - 01/2003
9	Biological ProductsIBA 01/2022 - 12/2006
9	Leukocyte L1 Antigen Complex (Calgranulin)IBA 01/2021 - 12/2012
9	C-Reactive ProteinIBA 01/2020 - 09/2002
8	Azathioprine (Imuran)FDA LinkGeneric 01/2018 - 09/2006
8	Tumor Necrosis Factor InhibitorsIBA 01/2018 - 06/2007
7	Biomarkers (Surrogate Marker)IBA 01/2022 - 12/2012
7	AntibodiesIBA 11/2021 - 09/2007
7	Mesalamine (Mesalazine)FDA LinkGeneric 12/2018 - 10/2002
7	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 06/2015 - 09/2002
6	Budesonide (Pulmicort)FDA LinkGeneric 11/2019 - 01/2002
5	Capsules (Microcapsules)IBA 01/2022 - 08/2015
5	SteroidsIBA 01/2022 - 09/2006
5	Phenobarbital (Luminal)FDA Link 01/2018 - 10/2004
4	upadacitinibIBA 10/2022 - 01/2020
4	Immunosuppressive Agents (Immunosuppressants)IBA 01/2022 - 06/2011
4	IntegrinsIBA 12/2021 - 01/2017
4	ozanimodIBA 07/2021 - 05/2016
3	CytokinesIBA 01/2022 - 01/2003
3	risankizumabIBA 01/2022 - 01/2017
3	Janus Kinase 1IBA 01/2022 - 01/2020
3	golimumab FDA Link 01/2020 - 06/2015
3	tofacitinibIBA 01/2020 - 01/2017
3	Anti-Bacterial Agents (Antibiotics)IBA 09/2014 - 04/2005
3	Certolizumab Pegol FDA Link 03/2014 - 08/2010
2	Creatine Kinase (Creatine Phosphokinase)IBA 10/2022 - 01/2022
2	InterleukinsIBA 01/2022 - 01/2022
2	Ustekinumab (CNTO 1275)FDA Link 01/2022 - 01/2018
2	Sphingosine-1-Phosphate ReceptorsIBA 01/2021 - 01/2020
2	Proteins (Proteins, Gene)FDA Link 01/2020 - 01/2016
2	ontamalimabIBA 01/2018 - 06/2015
2	Immunologic Factors (Immunomodulators)IBA 01/2018 - 12/2017
2	Immunoglobulin G (IgG)IBA 01/2016 - 10/2008
2	laquinimodIBA 08/2015 - 06/2015
2	Cyclosporine (Ciclosporin)FDA LinkGeneric 03/2004 - 10/2003
1	amiselimodIBA 06/2022
1	etrolizumabIBA 01/2022
1	GLPG0634IBA 01/2022
1	mirikizumabIBA 01/2022
1	Peptides (Polypeptides)IBA 12/2021
1	OligodeoxyribonucleotidesIBA 01/2020
1	GED0301IBA 01/2020
1	Biosimilar PharmaceuticalsIBA 02/2019
1	Peroxidase (Myeloperoxidase)IBA 01/2019
1	Messenger RNA (mRNA)IBA 01/2019
1	Prostaglandins AIBA 01/2019
1	Cell Adhesion Molecule-1IBA 01/2018
1	LigandsIBA 01/2018
1	Natalizumab (Tysabri)FDA Link 01/2018
1	Prednisone (Sone)FDA LinkGeneric 12/2017
1	GelsIBA 10/2017
1	LactoferrinIBA 07/2017

Therapy/Procedure

48	Therapeutics 01/2022 - 10/2002
6	Biological Therapy 01/2022 - 12/2006
3	Remission Induction 11/2019 - 02/2008
2	Aftercare (After-Treatment) 01/2022 - 01/2020
2	Colectomy 09/2011 - 02/2010
2	Restorative Proctocolectomy 02/2010 - 09/2009
2	Enema (Enemas) 12/2008 - 10/2002